A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples